Loading clinical trials...
Loading clinical trials...
The prospect of disease-modifying therapies in the pipeline for Alzheimer's Disease (AD) has intensified efforts to use brain imaging more effectively for diagnosis and monitoring of dementing illness...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sunnybrook Health Sciences Centre
Collaborators
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT07531732 · Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease
NCT07290387 · Alzheimer Disease, Dementia, and more
NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more
NCT06635876 · Dementia, Caregiver Burden
Sunnybrook Health Sciences Centre
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions